Physician profile
Alan J Weinstein
NPI 1881654267
$24,254.45
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,298 · 2020: $8,031 · 2021: $7,556 · 2022: $316 · 2023: $14.61 · 2024: $38.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19,798.97 | 2019-2022 | |
| Novo Nordisk INC | $884.86 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $697.30 | 2019-2022 | |
| Lilly USA, LLC | $540.91 | 2019-2022 | |
| Abbvie INC. | $372.18 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $355.22 | 2019-2022 | |
| Valeritas, INC. | $340.46 | 2019 | |
| Medtronic Minimed, INC. | $226.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $187.90 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.44 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $123.71 | 2019-2021 | |
| Medtronic, INC. | $88.71 | 2021-2022 | |
| Edwards Lifesciences Corporation | $86.99 | 2022 | |
| Mannkind Corporation | $59.40 | 2020 | |
| Abbott Laboratories | $53.28 | 2019-2024 | Diamondback Peripheral |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $49.95 | 2019-2020 | |
| Ibsa Pharma INC. | $43.64 | 2019-2021 | |
| Lifescan, INC. | $37.41 | 2020-2021 | |
| Tandem Diabetes Care, INC. | $34.09 | 2019-2020 | |
| Lemaitre Vascular, INC. | $33.62 | 2023-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Zealand Pharma US, INC. | $21.10 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.60 | 2022 | |
| Companion Medical, INC. | $16.25 | 2019 | |
| Gilead Sciences, INC. | $15.34 | 2019 | |
| Endo Pharmaceuticals INC. | $13.44 | 2020 | |
| Senseonics, Incorporated | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.